An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: results from a randomized placebo-controlled trial (the Step study).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples